Clinical Trial Update: Sodium Citrate in Smell Retraining for People With Post-COVID-19 Olfactory Dysfunction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating sodium citrate for smell retraining in people with post-COVID-19 olfactory dysfunction; the study is currently active but not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anosmia
• Olfactory Disorders
• Post-acute Sequelae of Sars-cov-2 Infection

Drugs mentioned

• Sodium citrate (trisodium citrate)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Long Haul COVID-19, Post-Acute COVID-19 Syndrome | Phase 2 | Status: ACTIVE_NOT_RECRUITING